Xlife Sciences AG

Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025

Xlife Sciences AG enables international co-investors to enter the stock and is planning a dual listing on the London Stock Exchange Group (LSEG)

Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures

Xlife Sciences AG Completes Strategic Review Process by Q3 2024

Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Sparks Segment of SIX

Xlife Sciences AG Reports Success in Liver Diagnostics – x-nuclear diagnostics GmbH Achieves Market Readiness